Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Published in: Cancer and Metastasis Reviews 4/2018

01-12-2018

Cancers of the eye

Authors: Abhilasha Maheshwari, Paul T. Finger

Published in: Cancer and Metastasis Reviews | Issue 4/2018

Login to get access

Abstract

Ocular cancers are unique among the diseases of the eye, threatening both vision and life. In most cases, the diagnosis can be made utilizing a careful clinical history and specialized ocular examination. Eye cancer diagnosis relies heavily on imaging techniques such as high-frequency ultrasound, fluorescein angiography, anterior and posterior segment optical coherence tomography, computed tomography (CT), and magnetic resonance imaging (MRI). Once the diagnosis is established, treatment decisions depend on the tumor’s location, size, local extension, patterns of growth, and secondary complications. Treatment options include observation, local resection, chemotherapy (topical, intravenous, intra-arterial, or intravitreal), and radiation (ophthalmic plaque or external beam). Enucleation or exenteration is only employed if these eye- and vision-sparing treatments are not possible. The core of this comprehensive review is a consecutive series of the most common ocular tumor of each structure of the eye, anterior to posterior, including basal cell carcinoma of the eyelid, squamous conjunctival neoplasia, choroidal melanoma, retinoblastoma, ocular adnexal lymphoma, and metastatic orbital tumors.
Literature
1.
Margo, C. E., & Waltz, K. (1993). Basal cell carcinoma of the eyelid and periocular skin. Survey of Ophthalmology, 38(2), 169–192.CrossRefPubMed
2.
Esmaeli, B., Dutton, J. J., Graue, G. F., et al. (2016). Eyelid carcinoma. In M. B. Amin, S. B. Edge, F. L. Greene, et al. (Eds.), AJCC cancer staging manual (pp. 779–785). New York: Springer International Publishing.
3.
Bakis, S., Irwig, L., Wood, G., & Wong, D. (2004). Exfoliative cytology as a diagnostic test for basal cell carcinoma: a meta-analysis. The British Journal of Dermatology, 150(5), 829–836.CrossRefPubMed
4.
Cook, B. E., & Bartley, G. B. (2001). Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology, 108(11), 2088–2098.CrossRefPubMed
5.
Kokoszka, A., & Scheinfeld, N. (2003). Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery [et al.], 29(6), 566–571.
6.
Lindgren, G., & Larkö, O. (1997). Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. Journal of the American Academy of Dermatology, 36(5 Pt 1), 742–746.CrossRefPubMed
7.
Tuppurainen, K. (1995). Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8-year period. Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie, 233(4), 205–208.CrossRefPubMed
8.
Hughes, W. L. (1986). Reconstructive surgery of the eyelids. Advances in Ophthalmic Plastic and Reconstructive Surgery, 5, 25–87.PubMed
9.
Kopecky, A., Koch, K. R., Bucher, F., Cursiefen, C., & Heindl, L. M. (2016). Results of Cutler-Beard procedure for reconstruction of extensive full thickness upper eyelid defects following tumor resection. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 113(4), 309–313.CrossRef
10.
Belmajdoub, M., Jacomet, P.-V., Benillouche, P., & Galatoire, O. (2015). Upper eyelid reconstruction with the Cutler-Beard flap technique: retrospective study of 16 cases. Journal Français d'Ophtalmologie, 38(7), 607–614.CrossRefPubMed
11.
Leibovitch, I., McNab, A., Sullivan, T., Davis, G., & Selva, D. (2005). Orbital invasion by periocular basal cell carcinoma. Ophthalmology, 112(4), 717–723.CrossRefPubMed
12.
Karabulut, G. O., Kaynak, P., Ozturker, C., Fazil, K., Ocak, O. B., & Taskapılı, M. (2017). Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area. Indian Journal of Ophthalmology, 65(1), 48–51.CrossRefPubMedPubMedCentral
13.
de Macedo, E. M. S., Carneiro, R. C., de Lima, P. P., Silva, B. G., & Matayoshi, S. (2015). Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial. BMC Ophthalmology, 15, 35.CrossRefPubMedPubMedCentral
14.
Macha, M. A., Batra, S. K., & Ganti, A. K. (2013). Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma. Cancer Management and Research, 5, 197–203.PubMedPubMedCentral
15.
Ozgur, O. K., Yin, V., Chou, E., Ball, S., Kies, M., William, W. N., Migden, M., Thuro, B. A., & Esmaeli, B. (2015). Hedgehog pathway inhibition for locally advanced periocular basal cell carcinoma and basal cell nevus syndrome. American Journal of Ophthalmology, 160(2), 220–227.CrossRefPubMed
16.
Jefford, M., Kiffer, J. D., Somers, G., Daniel, F. J., & Davis, I. D. (2004). Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ Journal of Surgery, 74(8), 704–705.CrossRefPubMed
17.
Lee, G. A., & Hirst, L. W. (1995). Ocular surface squamous neoplasia. Survey of Ophthalmology, 39(6), 429–450.CrossRefPubMed
18.
Sun, E. C., Fears, T. R., & Goedert, J. J. (1997). Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 6(2), 73–77.
19.
Lee, G. A., & Hirst, L. W. (1992). Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane. A 10-year survey. Archives of Ophthalmology (Chicago, III.: 1960), 110(4), 525–527.CrossRef
20.
Char, D. H., Crawford, J. B., Howes, E. L., & Weinstein, A. J. (1992). Resection of intraocular squamous cell carcinoma. The British Journal of Ophthalmology, 76(2), 123–125.CrossRefPubMedPubMedCentral
21.
Semenova, E. A., Milman, T., Finger, P. T., Natesh, S., Kurli, M., Schneider, S., Iacob, C. E., & McCormick, S. A. (2009). The diagnostic value of exfoliative cytology vs histopathology for ocular surface squamous neoplasia. American Journal of Ophthalmology, 148(5), 772–778.CrossRefPubMed
22.
Finger, P. T., Tran, H. V., Turbin, R. E., et al. (2003). High-frequency ultrasonographic evaluation of conjunctival intraepithelial neoplasia and squamous cell carcinoma. Archives of Ophthalmology (Chicago, III.: 1960), 121(2), 168–172.CrossRef
23.
Conway, R. M., Graue, G. F., Pelayes, D., et al. (2016). Conjunctival carcinoma. In M. B. Amin, S. B. Edge, F. L. Greene, et al. (Eds.), AJCC cancer staging manual (pp. 787–793). New York: Springer International Publishing.
24.
Finger, P. T. (2005). “Finger-tip” cryotherapy probes: treatment of squamous and melanocytic conjunctival neoplasia. The British Journal of Ophthalmology, 89(8), 942–945.CrossRefPubMedPubMedCentral
25.
Yousef, Y. A., & Finger, P. T. (2012). Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases. Ophthalmology, 119(2), 233–240.CrossRefPubMed
26.
Chaugule, S. S., Park, J., & Finger, P. T. (2018). Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: is surgery necessary? Indian Journal of Ophthalmology, 66(1), 55.CrossRefPubMedPubMedCentral
27.
Karp, C. L., Galor, A., Chhabra, S., Barnes, S. D., & Alfonso, E. C. (2010). Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology, 117(12), 2241–2246.CrossRefPubMed
28.
Graue, G. F., Tena, L. B., & Finger, P. T. (2011). Electron beam radiation for conjunctival squamous carcinoma. Ophthalmic Plastic and Reconstructive Surgery, 27(4), 277–281.CrossRefPubMed
29.
Teng, C. C., Chin, K. J., & Finger, P. T. (2009). Subconjunctival ranibizumab for squamous cell carcinoma of the conjunctiva with corneal extension. The British Journal of Ophthalmology, 93(6), 837–838.CrossRefPubMed
30.
Finger, P. T. (2009). Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects. Survey of Ophthalmology, 54(5), 545–568.CrossRefPubMed
31.
Fraunfelder, F. T., Wallace, T. R., Farris, H. E., et al. (1977). The role of cryosurgery in external ocular and periocular disease. Transactions. Section of Ophthalmology. American Academy of Ophthalmology and Otolaryngology, 83(4 Pt 1), 713–724.
32.
Erie, J. C., Campbell, R. J., & Liesegang, T. J. (1986). Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology, 93(2), 176–183.CrossRefPubMed
33.
Iliff, W. J., Marback, R., & Green, W. R. (1975). Invasive squamous cell carcinoma of the conjunctiva. Archives of Ophthalmology (Chicago, III.: 1960), 93(2), 119–122.CrossRef
34.
35.
Bishop, J. O., & Madson, E. C. (1975). Retinoblastoma. Review of the current status. Survey of Ophthalmology, 19(6), 342–366.PubMed
36.
Abramson, D. H., Frank, C. M., Susman, M., Whalen, M. P., Dunkel, I. J., & Boyd, N. W. (1998). Presenting signs of retinoblastoma. The Journal of Pediatrics, 132(3 Pt 1), 505–508.CrossRefPubMed
37.
Ainbinder, D. J., Haik, B. G., Frei, D. F., Gupta, K. L., & Mafee, M. F. (1996). Gadolinium enhancement: improved MRI detection of retinoblastoma extension into the optic nerve. Neuroradiology, 38(8), 778–781.CrossRefPubMed
38.
Shields, C. L., Fulco, E. M., Arias, J. D., et al. (2013). Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (London, England), 27(2), 253–264.CrossRef
39.
Mallipatna, A. C., Gallie, B. L., Chevez-Barrios, P., et al. (2016). Retinoblastoma. In M. B. Amin, S. B. Edge, F. L. Greene, et al. (Eds.), AJCC cancer staging manual (pp. 819–831). New York: Springer International Publishing.
40.
Shields, C. L., Schoenberg, E., Kocher, K., Shukla, S. Y., Kaliki, S., & Shields, J. A. (2013). Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases: results based on age at presentation. Ophthalmology, 120(2), 311–316.CrossRefPubMed
41.
Karcioglu, Z. A., Gordon, R. A., & Karcioglu, G. L. (1985). Tumor seeding in ocular fine needle aspiration biopsy. Ophthalmology, 92(12), 1763–1767.CrossRefPubMed
42.
Shields, C. L., Shields, J. A., Cater, J., Othmane, I., Singh, A. D., & Micaily, B. (2001). Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology, 108(11), 2116–2121.CrossRefPubMed
43.
Hernandez, J. C., Brady, L. W., Shields, J. A., Shields, C. L., DePotter, P., Karlsson, U. L., Markoe, A. M., Amendola, B. E., & Singh, A. (1996). External beam radiation for retinoblastoma: results, patterns of failure, and a proposal for treatment guidelines. International Journal of Radiation Oncology, Biology, Physics, 35(1), 125–132.CrossRefPubMed
44.
Honavar, S. G., & Singh, A. D. (2005). Management of advanced retinoblastoma. Ophthalmology Clinics of North America, 18(1), 65–73.CrossRefPubMed
45.
Munier, F. L., Gaillard, M.-C., Balmer, A., Soliman, S., Podilsky, G., Moulin, A. P., & Beck-Popovic, M. (2012). Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. The British Journal of Ophthalmology, 96(8), 1078–1083.CrossRefPubMed
46.
Shields, C. L., Santos, M. C., Diniz, W., et al. (1999). Thermotherapy for retinoblastoma. Archives of Ophthalmology (Chicago, III.: 1960), 117(7), 885–893.CrossRef
47.
American Brachytherapy Society - Ophthalmic Oncology Task Force., ABS – OOTF Committee. (2014). The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy, 13(1), 1–14.CrossRef
48.
Abramson, D. H., & Frank, C. M. (1998). Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology, 105(4), 573–579 discussion 579-580.CrossRefPubMed
49.
Murthy, R., Honavar, S. G., Naik, M. N., & Reddy, V. A. P. (2005). Retinoblastoma. In L. Dutta (Ed.), Modern ophthalmology (Vol. 2, pp. 849–859). New Delhi: Jaypee Brothers Medical Publishers (P) Ltd.
50.
Gupta, R., Vemuganti, G. K., Reddy, V. A. P., & Honavar, S. G. (2009). Histopathologic risk factors in retinoblastoma in India. Archives of Pathology & Laboratory Medicine, 133(8), 1210–1214.
51.
Finger, P. T., Harbour, J. W., & Karcioglu, Z. A. (2002). Risk factors for metastasis in retinoblastoma. Survey of Ophthalmology, 47(1), 1–16.CrossRefPubMed
52.
Gichigo, E. N., Kariuki-Wanyoike, M. M., Kimani, K., & Nentwich, M. M. (2015). Retinoblastoma in Kenya: survival and prognostic factors. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 112(3), 255–260.CrossRef
53.
Singh, A. D., Bergman, L., & Seregard, S. (2005). Uveal melanoma: epidemiologic aspects. Ophthalmology Clinics of North America, 18(1), 75–84 viii.CrossRefPubMed
54.
Hu, D.-N., Yu, G.-P., McCormick, S. A., Schneider, S., & Finger, P. T. (2005). Population-based incidence of uveal melanoma in various races and ethnic groups. American Journal of Ophthalmology, 140(4), 612–617.CrossRefPubMed
55.
Hawkins, B. S., & Collaborative Ocular Melanoma Study Group. (2004). The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. American Journal of Ophthalmology, 138(6), 936–951.CrossRefPubMed
56.
Inskip, P. D., Devesa, S. S., & Fraumeni, J. F. (2003). Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control CCC, 14(3), 251–257.CrossRefPubMed
57.
Singh, A. D., & Topham, A. (2003). Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology, 110(5), 956–961.CrossRefPubMed
58.
Guénel, P., Laforest, L., Cyr, D., Févotte, J., Sabroe, S., Dufour, C., Lutz, J. M., & Lynge, E. (2001). Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes Control CCC, 12(5), 451–459.CrossRefPubMed
59.
Lutz, J.-M., Cree, I., Sabroe, S., Kvist, T. K., Clausen, L. B., Afonso, N., Ahrens, W., Ballard, T. J., Bell, J., Cyr, D., Eriksson, M., Févotte, J., Guénel, P., Hardell, L., Jöckel, K. H., Miranda, A., Merletti, F., Morales-Suarez-Varela, M. M., Stengrevics, A., & Lynge, E. (2005). Occupational risks for uveal melanoma results from a case-control study in nine European countries. Cancer Causes Control CC, 16(4), 437–447.CrossRef
60.
Vajdic, C. M., Kricker, A., Giblin, M., McKenzie, J., Aitken, J., Giles, G. G., & Armstrong, B. K. (2002). Sun exposure predicts risk of ocular melanoma in Australia. International Journal of Cancer, 101(2), 175–182.CrossRefPubMed
61.
Finger, P. T. (2015). Ocular malignancies: choroidal melanoma, retinoblastoma, ocular adnexal lymphoma and eyelid cancer. In B. O’Sullivan & S. H. Huang (Eds.), UICC manual of clinical oncology (pp. 726–745). West Sussex: Wiley.CrossRef
62.
Lemaître, S., Zmuda, M., Jacomet, P. V., Lévy-Gabriel, C., Dendale, R., Berges, O., Fréneaux, P., Mariani, P., Desjardins, L., Galatoire, O., & Cassoux, N. (2017). Small choroidal melanoma revealed by a large extrascleral extension. Ocular Oncology and Pathology, 3(3), 240–246.CrossRefPubMedPubMedCentral
63.
Lorenzano, D., Miszkiel, K., & Rose, G. E. (2017). Orbital melanoma masquerading as a “galloping haemangioma.”. Orbit (Amsterdam, Netherlands), 36(2), 81–83.
64.
Freton, A., Chin, K.J., Raut, R. Tena, L.B.Kivelä, T., Finger, P. T. (2002). Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients. European Journal of Ophthalmology, 22(2), 236–243.
65.
Augsburger, J. J., & Shields, J. A. (1984). Fine needle aspiration biopsy of solid intraocular tumors: indications, instrumentation and techniques. Ophthalmic Surgery, 15(1), 34–40.PubMed
66.
Kivela, T., Simpson, E. R., Grossniklaus, H. E., et al. (2016). Uveal melanoma. In M. B. Amin, S. B. Edge, F. L. Greene, et al. (Eds.), AJCC cancer staging manual (pp. 805–813). New York: Springer International Publishing.
67.
Earle, J., Kline, R. W., & Robertson, D. M. (1987). Selection of iodine 125 for the Collaborative Ocular Melanoma Study. Archives of Ophthalmology, 105(6), 763–764.CrossRefPubMed
68.
De Potter, P., Shields, C. L., Shields, J. A., Cater, J. R., & Brady, L. W. (1996). Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Archives of Ophthalmology (Chicago, III.: 1960), 114(11), 1357–1365.CrossRef
69.
Finger, P. T., Chin, K. J., & Duvall, G. (2009). Palladium-103 for Choroidal Melanoma Study Group. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Ophthalmology, 116(4), 790–796.CrossRefPubMed
70.
Maheshwari, A., Finger, P. T. (2018) A 12-year study of slotted palladium-103 plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve. American Journal of Ophthalmology, 188, 60–69.
71.
Chiu-Tsao, S.-T., Astrahan, M. A., Finger, P. T., et al. (2012). Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS. Medical Physics, 39(10), 6161–6184.CrossRefPubMed
72.
Shields, C. L., Shields, J. A., Cater, J., et al. (2000). Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Archives of Ophthalmology (Chicago, III.: 1960), 118(9), 1219–1228.CrossRef
73.
Finger, P. T., Lu, D., Buffa, A., DeBlasio, D. S., & Bosworth, J. L. (1993). Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 27(4), 849–854.CrossRefPubMed
74.
Gragoudas, E. S., Seddon, J. M., Egan, K., Glynn, R., Munzenrider, J., Austin-Seymour, M., Goitein, M., Verhey, L., Urie, M., & Koehler, A. (1987). Long-term results of proton beam irradiated uveal melanomas. Ophthalmology, 94(4), 349–353.CrossRefPubMed
75.
Krema, H., Somani, S., Sahgal, A., Xu, W., Heydarian, M., Payne, D., McGowan, H., Michaels, H., Simpson, E. R., & Laperriere, N. (2009). Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up. The British Journal of Ophthalmology, 93(9), 1172–1176.CrossRefPubMed
76.
Char, D. H., Bove, R., & Phillips, T. L. (2003). Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments. American Journal of Ophthalmology, 136(1), 180–182.CrossRefPubMed
77.
Wachtlin, J., Bechrakis, N. E., & Foerster, M. H. (2005). Photodynamic therapy with verteporfin for uveal melanoma. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 102(3), 241–246.CrossRef
78.
Wilson, D. J., & Klein, M. L. (2002). Choroidal melanoma treated with cryotherapy. Archives of Ophthalmology, 120(3), 393–395.PubMed
79.
Augsburger, J. J., & Gamel, J. W. (1990). Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer, 66(7), 1596–1600.CrossRefPubMed
80.
Collaborative Ocular Melanoma Study Group. (2001). Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Archives of Ophthalmology (Chicago, III.: 1960), 119(5), 670–676.CrossRef
81.
Sjö, L. D., Ralfkiaer, E., Prause, J. U., et al. (2008). Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Investigative Ophthalmology & Visual Science, 49(8), 3283–3288.CrossRef
82.
Coupland, S. E., Hellmich, M., Auw-Haedrich, C., Lee, W. R., & Stein, H. (2004). Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie, 242(2), 130–145.CrossRefPubMed
83.
Knowles, D. M., Jakobiec, F. A., McNally, L., & Burke, J. S. (1990). Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Human Pathology, 21(9), 959–973.CrossRefPubMed
84.
Shields, C. L., Shields, J. A., Carvalho, C., Rundle, P., & Smith, A. F. (2001). Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology, 108(5), 979–984.CrossRefPubMed
85.
Heegaard, S., Chevez-Barrios, P., White, V. A., Coupland, S. E., & Finger, P. T. (2016). Ocular adnexal lymphoma. In M. B. Amin, S. B. Edge, F. L. Greene, et al. (Eds.), AJCC cancer staging manual (pp. 849–854). New York: Springer International Publishing.
86.
Hepler, R. S. (1972). Clinical diagnosis of orbital tumors. Radiologic Clinics of North America, 10(1), 3–10.PubMed
87.
Gerbino, G., Boffano, P., Benech, R., et al. (2014). Orbital lymphomas: clinical and radiological features. Journal of Cranio-Maxillo-Facial Surgery: Official Publication of the European Association for Cranio-Maxillo-Facial Surgery, 42(5), 508–512.CrossRef
88.
Coupland, S. E., Krause, L., Delecluse, H. J., et al. (1998). Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology, 105(8), 1430–1441.CrossRef
89.
English, J. F., & Sullivan, T. J. (2015). The role of FDG-PET in the diagnosis and staging of ocular adnexal lymphoproliferative disease. Orbit (Amsterdam, Netherlands), 34(5), 284–291.
90.
Hui, K.-H., Pfeiffer, M. L., & Esmaeli, B. (2012). Value of positron emission tomography/computed tomography in diagnosis and staging of primary ocular and orbital tumors. Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society, 26(4), 365–371.CrossRef
91.
Fung, C. Y., Tarbell, N. J., Lucarelli, M. J., Goldberg, S. I., Linggood, R. M., Harris, N. L., & Ferry, J. A. (2003). Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. International Journal of Radiation Oncology, Biology, Physics, 57(5), 1382–1391.CrossRefPubMed
92.
Leget, G. A., & Czuczman, M. S. (1998). Use of rituximab, the new FDA-approved antibody. Current Opinion in Oncology, 10(6), 548–551.CrossRefPubMed
93.
Maloney, D. G., Grillo-López, A. J., White, C. A., et al. (1997). IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma. Blood, 90(6), 2188–2195.PubMed
94.
McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., Jain, V., Ho, A. D., Lister, J., Wey, K., Shen, D., & Dallaire, B. K. (1998). Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 16(8), 2825–2833.CrossRef
95.
Chan, C.-C., Smith, J. A., Shen, D. F., Ursea, R., LeHoang, P., & Grossniklaus, H. E. (2004). Helicobacter pylori (H. pylori) molecular signature in conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma. Histology and Histopathology, 19(4), 1219–1226.PubMedPubMedCentral
96.
Ferreri, A. J. M., Guidoboni, M., Ponzoni, M., de Conciliis, C., Dell'Oro, S., Fleischhauer, K., Caggiari, L., Lettini, A. A., Dal Cin, E., Ieri, R., Freschi, M., Villa, E., Boiocchi, M., & Dolcetti, R. (2004). Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. Journal of the National Cancer Institute, 96(8), 586–594.CrossRefPubMed
97.
Kirkegaard, M. M., Rasmussen, P. K., Coupland, S. E., Esmaeli, B., Finger, P. T., Graue, G. F., Grossniklaus, H. E., Honavar, S. G., Khong, J. J., McKelvie, P. A., Mulay, K., Prause, J. U., Ralfkiaer, E., Sjö, L. D., Toft, P. B., Vemuganti, G. K., Thuro, B. A., Curtin, J., & Heegaard, S. (2016). Conjunctival lymphoma—an international multicenter retrospective study. JAMA Ophthalmology, 134(4), 406–414.CrossRefPubMed
98.
Rasmussen, P. K., Coupland, S. E., Finger, P. T., Graue, G. F., Grossniklaus, H. E., Honavar, S. G., McKelvie, P., Mulay, K., Prause, J. U., Ralfkiaer, E., Sjö, L. D., & Heegaard, S. (2014). Ocular adnexal follicular lymphoma: a multicenter international study. JAMA Ophthalmology, 132(7), 851–858.CrossRefPubMed
99.
Svendsen, F. H., Rasmussen, P. K., Coupland, S. E., Esmaeli, B., Finger, P. T., Graue, G. F., Grossniklaus, H. E., Honavar, S. G., Khong, J. J., McKelvie, P. A., Mulay, K., Ralfkiaer, E., Sjö, L. D., Vemuganti, G. K., Thuro, B. A., Curtin, J., & Heegaard, S. (2017). Lymphoma of the eyelid—an international multicenter retrospective study. American Journal of Ophthalmology, 177, 58–68.CrossRefPubMed
100.
Jenkins, C., Rose, G. E., Bunce, C., et al. (2000). Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. The British Journal of Ophthalmology, 84(8), 907–913.CrossRefPubMedPubMedCentral
101.
McKelvie, P. A., McNab, A., Francis, I. C., Fox, R., & O’Day, J. (2001). Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clinical & Experimental Ophthalmology, 29(6), 387–393.CrossRef
102.
103.
Ferry, A. P., & Font, R. L. (1974). Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Archives of Ophthalmology (Chicago, III.: 1960), 92(4), 276–286.CrossRef
104.
Kennedy, R. E. (1984). An evaluation of 820 orbital cases. Transactions of the American Ophthalmological Society, 82, 134–157.PubMedPubMedCentral
105.
Shields, J. A., Bakewell, B., Augsburger, J. J., & Flanagan, J. C. (1984). Classification and incidence of space-occupying lesions of the orbit. A survey of 645 biopsies. Archives of Ophthalmology (Chicago, III.: 1960), 102(11), 1606–1611.CrossRef
106.
Goldberg, R. A., Rootman, J., & Cline, R. A. (1990). Tumors metastatic to the orbit: a changing picture. Survey of Ophthalmology, 35(1), 1–24.CrossRefPubMed
107.
Günalp, I., & Gündüz, K. (1995). Metastatic orbital tumors. Japanese Journal of Ophthalmology, 39(1), 65–70.PubMed
108.
Shields, C. L., Shields, J. A., & Peggs, M. (1988). Tumors metastatic to the orbit. Ophthalmic Plastic and Reconstructive Surgery, 4(2), 73–80.CrossRefPubMed
109.
Shields, J. A., Shields, C. L., Brotman, H. K., Carvalho, C., Perez, N., & Eagle, R. C. (2001). Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Ophthalmic Plastic and Reconstructive Surgery, 17(5), 346–354.CrossRefPubMed
110.
Bersani, T. A., Costello, J. J., Mango, C. A., & Streeten, B. W. (1994). Benign approach to a malignant orbital tumor: metastatic renal cell carcinoma. Ophthalmic Plastic and Reconstructive Surgery, 10(1), 42–44.CrossRefPubMed
111.
Betharia, S. M. (1985). Metastatic orbital carcinoma of thyroid. Indian Journal of Ophthalmology, 33(3), 191–193.PubMed
112.
Drake, E. T., & Dobben, G. D. (1959). Leiomyosarcoma of the uterus with unusual metastases. Journal of the American Medical Association, 170(11), 1294–1298.CrossRefPubMed
113.
Rush, J. A., Older, J. J., & Richman, A. V. (1981). Testicular seminoma metastatic to the orbit. American Journal of Ophthalmology, 91(2), 258–260.CrossRefPubMed
114.
Saxena, R. B., Mathur, R. N., & Sonani, S. Z. (1975). Orbital metastasis of mixed parotid tumour. Indian Journal of Ophthalmology, 23(2), 23–24.PubMed
115.
Seretan, E. L. (1981). Metastatic adenocarcinoma from the stomach to the orbit. Archives of Ophthalmology (Chicago, III.: 1960), 99(8), 1469.CrossRef
116.
Smiley, S. S. (1965). An orbital metastasis from the urinary bladder. Archives of Ophthalmology (Chicago, III.: 1960), 74(6), 809–810.CrossRef
117.
Stewart, W. B., Newman, N. M., Cavender, J. C., & Spencer, W. H. (1978). Fibrous histiocytoma metastatic to the orbit. Archives of Ophthalmology (Chicago, III.: 1960), 96(5), 871–873.CrossRef
118.
Healy, J. F. (1983). Computed tomographic evaluation of metatases to the orbit. Annals of Ophthalmology, 15(11), 1026–1029.PubMed
119.
Hanson, M. W., Schneider, A. M., Enterline, D. S., Feldman, J. M., & Gockerman, J. P. (1998). Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 39(4), 647–650.
120.
Glassburn, J. R., Klionsky, M., & Brady, L. W. (1984). Radiation therapy for metastatic disease involving the orbit. American Journal of Clinical Oncology, 7(2), 145–148.CrossRefPubMed
121.
Saitoh, A., Amemiya, T., & Tsuda, N. (1997). Metastasis of breast carcinoma to eyelid and orbit of a postmenopausal woman: good response to tamoxifen therapy. Ophthalmologica. Journal International D’ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde, 211(6), 362–366.CrossRefPubMed
122.
Kuo, S.-C., Hsiao, S.-C., Chiou, C.-C., Chen, F.-F., & Huang, K.-C. (2008). Metastatic carcinoma of the breast: a case with the unusual presentation of unilateral periorbital edema. Japanese Journal of Ophthalmology, 52(4), 305–307.CrossRefPubMed
123.
Carriere, V. M., Karcioglu, Z. A., Apple, D. J., & Insler, M. S. (1982). A case of prostate carcinoma with bilateral orbital metastases and the review of the literature. Ophthalmology, 89(4), 402–406.CrossRefPubMed
124.
Kopelman, J. E., & Shorr, N. (1987). A case of prostatic carcinoma metastatic to the orbit diagnosed by fine needle aspiration and immunoperoxidase staining for prostatic specific antigen. Ophthalmic Surgery, 18(8), 599–603.PubMed
Metadata
Title
Cancers of the eye
Authors
Abhilasha Maheshwari
Paul T. Finger
Publication date
01-12-2018
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 4/2018
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-018-9762-9

Other articles of this Issue 4/2018

Cancer and Metastasis Reviews 4/2018 Go to the issue

OriginalPaper

Metabolic reprogramming of mitochondrial respiration in metastatic cancer

ReviewPaper

A contemporary review of male breast cancer: current evidence and unanswered questions

OriginalPaper

Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review

NON-THEMATIC REVIEW

WNT5A as a therapeutic target in breast cancer

NON-THEMATIC REVIEW

MACC1—the first decade of a key metastasis molecule from gene discovery to clinical translation

ReviewPaper

Pleiotropic effects of moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in cancer progression, invasiveness, and metastases
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits